Myricx Bio vs Sierra Oncology
Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
36 employees · est. 2019 · London, United Kingdom
Sierra Oncology
We are on a mission to deliver transformative therapies that treat rare forms of cancer
10 employees · est. 2004 · San Mateo, United States
Sierra Oncology is the older company (2019 vs 2004); Myricx Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Myricx Bio | Sierra Oncology |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2004 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | San Mateo, United States |
| Employees | ||
| Employees | 36 larger | 10 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $1.59B | $494.13M |
| Funding Rounds | ||
| Funding Rounds | 3 | 13 |
| Services | ||
| Services | Discovery and development of novel ADCs, Preclinical efficacy and safety testing, Clinical team expansion and regulatory affairs | Research and Development, Clinical Trials Execution, Product Development, Healthcare Partnerships, Global Access Programs |
| Target Customers | ||
| Target Customers | Oncologists, Pharmaceutical companies, Biotechnology partners, Research institutions | Healthcare Professionals, Patients with Chronic and Infectious Diseases, Institutional Investors, Healthcare Corporations, Global Health Organizations |
| Taxonomy | ||
| Taxonomy | BiotechAntibody Drug ConjugatesADC DevelopmentN-Myristoyltransferase InhibitorsNMT InhibitionOncology Treatment +8 | BiopharmaceuticalOncologyCancer TherapyRare Forms Of CancerJAK InhibitorMyelofibrosis +8 |
| Website | ||
| Website | myricxbio.com | sierraoncology.com |
About Myricx Bio
Myricx Bio is an innovative UK-based biotech company, established in 2019, with a mission to revolutionize cancer treatment through their novel technology. The company's tagline, "Developing a new class of ADCs based on NMT inhibition to treat cancer," reflects its pioneering approach in creating se...
About Sierra Oncology
Sierra Oncology, founded in 2004 and headquartered in the United States, is a late-stage biopharmaceutical company focused on delivering transformative therapies for rare cancers. Their mission, as articulated in their slogan, is clear: "We are on a mission to deliver transformative therapies that t...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Myricx Bio and Sierra Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Myricx Bio or Sierra Oncology moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Myricx Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Myricx Bio on 15 Jun 2026, and Sierra Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
